Shengwei Li (李生威) received his bachelor’s degree in Pharmaceutics from Jiangxi University of Chinese Medicine (JXUCM) in 2020 and his master’s degree in Biomedical Informatics from China Pharmaceutical University (CPU) in 2023. He joined JunLab in 2023. His research focuses on applying Epigenome-Wide Association Studies (EWAS) to investigate the role of DNA methylation in complex diseases.